EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Treatment Approaches to Granulomatosis with Polyangiitis and Microscopic Polyangiitis

Alvise Berti, Divi Cornec, Anisha B Dua

Rheumatic Disease Clinics of North America · 2023

DOI: 10.1016/j.rdc.2023.03.004 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Rheumatic Disease Clinics of North America, 2023. Verfasst von Alvise Berti und 2 weiteren Autor:innen. Beteiligte Einrichtung: Center for Medical Sciences (CISMed), Department of Cellular, Computational and Integrative Biology (CIBIO), University of Trento, and Division of Rh…. Hauptthemen laut MEDLINE: Microscopic Polyangiitis, Granulomatosis with Polyangiitis, Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 62 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

We have made significant headway in our ability to induce and maintain remission in patients with granulomatosis with polyangiitis and microscopic polyangiitis. With increased understanding of the pathogenesis of antineutrophilic cytoplasmic antibody-associated vasculitides (AAV), therapeutic targets have been identified and studied in clinical trials. From initial induction strategies including glucocorticoids and cyclophosphamide, we have discovered effective induction regimens with rituximab and complement inhibition that can significantly decrease the glucocorticoid cumulative doses in patients with AAV. There are many trials underway evaluating management strategies for refractory patients and exploring new and old therapies that may help to continuously improve outcomes for patients with AAV.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Microscopic PolyangiitisGranulomatosis with PolyangiitisAnti-Neutrophil Cytoplasmic Antibody-Associated VasculitisHumansRemission InductionRituximabAntibodies, Antineutrophil Cytoplasmic

Stichwörter der Autor:innen

ANCA vasculitisGranulomatosis with polyangiitisMicroscopic polyangiitisTreatment

Substanzen

RituximabAntibodies, Antineutrophil Cytoplasmic

Autor:innen und Institutionen

  • Center for Medical Sciences (CISMed), Department of Cellular, Computational and Integrative Biology (CIBIO), University of Trento, and Division of Rheumatology, Santa Chiara Hospital, APSS Trento, Italy.
  • Rheumatology Department, INSERM UMR1227 LBAI, Lymphocytes B, Autoimmunité et Immunothérapies, University of Brest, National Reference Center for Rare Systemic Autoimmune Diseases CERAINO, CHRU Brest, Brest, France. Elec…
  • Division of Rheumatology, Northwestern University Feinberg School of Medicine, 675 North Saint Clair Street, Suite 14-100, Chicago, IL 60611, USA.

Zitieren

APA

Berti, A., Cornec, D., & Dua, A. B. (2023). Treatment Approaches to Granulomatosis with Polyangiitis and Microscopic Polyangiitis. Rheumatic Disease Clinics of North America. https://doi.org/10.1016/j.rdc.2023.03.004

Vancouver

Berti A, Cornec D, Dua AB. Treatment Approaches to Granulomatosis with Polyangiitis and Microscopic Polyangiitis. Rheumatic Disease Clinics of North America. 2023. doi:10.1016/j.rdc.2023.03.004

BibTeX
@article{Berti2023,
  author = {Berti, Alvise and Cornec, Divi and Dua, Anisha B},
  title = {Treatment Approaches to Granulomatosis with Polyangiitis and Microscopic Polyangiitis},
  journal = {Rheumatic Disease Clinics of North America},
  year = {2023},
  doi = {10.1016/j.rdc.2023.03.004}
}
Kostenlos starten →